VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
dexamedatomidine
Preclinical
Small molecule
A
Armed Forces College of Medicine, Cairo, Egypt
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Breast Surgery
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Breast Surgery
Preclinical
Completed
Clinical
Trials by Indication
[1]
Breast Surgery
1 trial
Dexamedatomidine vs. Dexamethasone in Rhomboidal Intercostal Plain Block and Subserratus Block in Breast Surgery
Completed
·
—
·
N/A
·
NCT05385523
·
70 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for dexamedatomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
dexamedatomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for dexamedatomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Armed Forces College of Medicine, Cairo, Egypt company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
A
Armed Forces College of Medicine, Cairo, Egypt
Related News